Insider · CIK 0002031518
David Feltquate
Files at ITOS (iTeos Therapeutics, Inc.). First filing -, latest -.
David Feltquate files SEC Form 4 as officer at ITOS (iTeos Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; David Feltquate has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | UTender of shares Common Stock | -47,000 | - | - | 0 | Aug 29, 2025 |
| Dec 6, 2024 | ITOS iTeos Therapeutics, Inc. | AGrant or award Common Stock | +47,000 | $0.00 | $0 | 47,000 | Dec 6, 2024 |
Questions about David Feltquate
Answered from the filings on this page, as of the latest one.
Is David Feltquate buying or selling?
David Feltquate has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did David Feltquate's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Feltquate has 0.
Where does David Feltquate file Form 4?
David Feltquate has filed Form 4 at ITOS (iTeos Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.